Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
About this item
Full title
Author / Creator
Ferrari, Silvia Martina , Bocci, Guido , Di Desidero, Teresa , Elia, Giusy , Ruffilli, Ilaria , Ragusa, Francesca , Orlandi, Paola , Paparo, Sabrina Rosaria , Patrizio, Armando , Piaggi, Simona , La Motta, Concettina , Ulisse, Salvatore , Baldini, Enke , Materazzi, Gabriele , Miccoli, Paolo , Antonelli, Alessandro and Fallahi, Poupak
Publisher
Greece: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Greece: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor (TKI) of VEGFR1-VEGFR3, FGFR1-FGFR4, PDGFRα, RET and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) signaling networks involved in tumor angiogenesis. We have evaluated the antitumor activity of lenvatinib in primary anaplastic thyroid cancer (ATC) cells, in the hum...
Alternative Titles
Full title
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Authors, Artists and Contributors
Author / Creator
Bocci, Guido
Di Desidero, Teresa
Elia, Giusy
Ruffilli, Ilaria
Ragusa, Francesca
Orlandi, Paola
Paparo, Sabrina Rosaria
Patrizio, Armando
Piaggi, Simona
La Motta, Concettina
Ulisse, Salvatore
Baldini, Enke
Materazzi, Gabriele
Miccoli, Paolo
Antonelli, Alessandro
Fallahi, Poupak
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2012119245
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2012119245
Other Identifiers
ISSN
1021-335X
E-ISSN
1791-2431
DOI
10.3892/or.2018.6306
